780 Targeting Myeloid Cells with BO-112 Engages T Cell Immunity in Combination with Radiotherapy and Checkpoint Blockade in Preclinical Models and a Phase 1 Neoadjuvant Clinical Trial
Regular and Young Investigator Award Abstracts(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined